What is NDC 46287-030?

46287-030 is the product NDC for Atorvaliq, Atorvastatin calcium trihydrate 20 mg/5mL suspension, listed with the FDA by CMP Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Atorvastatin calcium trihydrate.

CMP Pharma, Inc., NDC labeler code 46287. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Atorvaliq?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Atorvaliq NDC 46287-030 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)46287-030Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46287-0030Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
46287-030-01	4628700300146287003001	150 mL in 1 BOTTLE (46287-030-01)Marketed from Mar 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atorvaliq
Generic name (nonproprietary): atorvaliq
Active ingredients: Atorvastatin calcium trihydrate — 20 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: CMP Pharma, Inc.NDC labeler code 46287
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 213260
Marketing start: Mar 1, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 46287-030_fb92775a-6d6d-4d62-ab23-045f16ec5895SPL ID fb92775a-6d6d-4d62-ab23-045f16ec5895SPL set ID 41fca2d8-7f3f-45b9-8974-81b89accc211RxCUI 2630760UNII 48A5M73Z4Q
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446287003001 followed by a unit qualifier and the quantity

Package 46287-0030-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 27, 2024.

Indications (excerpt from the label)

ATORVALIQ is indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 46287-030

What is NDC 46287-030?: 46287-030 is the product NDC for Atorvaliq, Atorvastatin calcium trihydrate 20 mg/5mL suspension, listed with the FDA by CMP Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Atorvaliq.
What is the active ingredient?: Atorvastatin calcium trihydrate.
Who is the labeler?: CMP Pharma, Inc., NDC labeler code 46287. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Atorvaliq?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.